Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review
Parisa Ghasemiyeh,1,2 Afshin Borhani-Haghighi,3 Iman Karimzadeh,1 Soliman Mohammadi-Samani,2,4 Afsaneh Vazin,1 Anahid Safari,5 Adnan I Qureshi6 1Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; 2Pharmaceutical Sciences Research Center, School...
Guardado en:
Autores principales: | Ghasemiyeh P, Borhani-Haghighi A, Karimzadeh I, Mohammadi-Samani S, Vazin A, Safari A, Qureshi AI |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f504207bee6845888e5142d0463359dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanisms and the clinical relevance of complex drug–drug interactions
por: Roberts AG, et al.
Publicado: (2018) -
Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug–Drug and Drug–Disease Interactions of Apatinib
por: Hongrui Liu, et al.
Publicado: (2021) -
Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Gabriela Rossi, et al.
Publicado: (2021) -
MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
por: N. V. Verlan, et al.
Publicado: (2017) -
Clinical and pharmacological monitoring of drug safety in pediatrics
por: N. V. Verlan, et al.
Publicado: (2016)